Cargando…
COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study
BACKGROUND: In patients with comorbidities such as chronic illness, the severity and mortality risk of the disease (COVID-19) are high. Even if they are fully vaccinated, they should follow all precautions for unvaccinated people because the vaccine may not provide them complete protection. As a res...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126288/ https://www.ncbi.nlm.nih.gov/pubmed/35615583 http://dx.doi.org/10.2147/RMHP.S365389 |
_version_ | 1784712095812550656 |
---|---|
author | Gebeyehu, Daniel Ayelegne Sisay, Endalkachew Molla, Bizuneh Terefe, Bewuketu |
author_facet | Gebeyehu, Daniel Ayelegne Sisay, Endalkachew Molla, Bizuneh Terefe, Bewuketu |
author_sort | Gebeyehu, Daniel Ayelegne |
collection | PubMed |
description | BACKGROUND: In patients with comorbidities such as chronic illness, the severity and mortality risk of the disease (COVID-19) are high. Even if they are fully vaccinated, they should follow all precautions for unvaccinated people because the vaccine may not provide them complete protection. As a result, understanding their response to a threat is essential because knowing their threat level can be a good predictor of behavioral changes and health-protective behaviors. METHODS: An institution-based cross-sectional mixed-method study design was used at the University of Gondar specialized hospital from May 1 to June 30, 2021. An interviewer-administered questionnaire was used for the quantitative, and tape recorders, field notes, and memos were properly taken during the in-depth interviews for the qualitative data. Multivariable logistic regression with consideration of adjusted odds ratio of 95% confidence interval and p-value of 0.05% was used for statistical significance. RESULTS: The study enrolled 239 people, with a 96% response rate, ranging from 24 to 67 years, with the majority (57.9%) male. Even after receiving the second dose of AstraZeneca, nearly half (46.5%) of participants with a chronic illness perceived a threat to COVID-19. The participant’s age ranges from 24 to 34 years [3.24 (AOR= 3.24 (95% CI: 1.08, 9.68))], patients who are student [2.38 (AOR= 2.38 (95% CI: 1.12, 5.06))], participants applying the recommended behavioral response [2.36 (AOR=2.36 (95% CI: 1.16, 4.81))] and duration of illness ranged from four to six-year [3.17 (AOR=3.17 (95% CI (1.05, 9.58))] were statistically associated with perceived threat. CONCLUSION: Most people with chronic illnesses do not see the disease as a threat. Particular emphasis should be placed on creating awareness programs and disseminating information through media on prevention, and ongoing health education is strongly advisable. |
format | Online Article Text |
id | pubmed-9126288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-91262882022-05-24 COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study Gebeyehu, Daniel Ayelegne Sisay, Endalkachew Molla, Bizuneh Terefe, Bewuketu Risk Manag Healthc Policy Original Research BACKGROUND: In patients with comorbidities such as chronic illness, the severity and mortality risk of the disease (COVID-19) are high. Even if they are fully vaccinated, they should follow all precautions for unvaccinated people because the vaccine may not provide them complete protection. As a result, understanding their response to a threat is essential because knowing their threat level can be a good predictor of behavioral changes and health-protective behaviors. METHODS: An institution-based cross-sectional mixed-method study design was used at the University of Gondar specialized hospital from May 1 to June 30, 2021. An interviewer-administered questionnaire was used for the quantitative, and tape recorders, field notes, and memos were properly taken during the in-depth interviews for the qualitative data. Multivariable logistic regression with consideration of adjusted odds ratio of 95% confidence interval and p-value of 0.05% was used for statistical significance. RESULTS: The study enrolled 239 people, with a 96% response rate, ranging from 24 to 67 years, with the majority (57.9%) male. Even after receiving the second dose of AstraZeneca, nearly half (46.5%) of participants with a chronic illness perceived a threat to COVID-19. The participant’s age ranges from 24 to 34 years [3.24 (AOR= 3.24 (95% CI: 1.08, 9.68))], patients who are student [2.38 (AOR= 2.38 (95% CI: 1.12, 5.06))], participants applying the recommended behavioral response [2.36 (AOR=2.36 (95% CI: 1.16, 4.81))] and duration of illness ranged from four to six-year [3.17 (AOR=3.17 (95% CI (1.05, 9.58))] were statistically associated with perceived threat. CONCLUSION: Most people with chronic illnesses do not see the disease as a threat. Particular emphasis should be placed on creating awareness programs and disseminating information through media on prevention, and ongoing health education is strongly advisable. Dove 2022-05-19 /pmc/articles/PMC9126288/ /pubmed/35615583 http://dx.doi.org/10.2147/RMHP.S365389 Text en © 2022 Gebeyehu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Gebeyehu, Daniel Ayelegne Sisay, Endalkachew Molla, Bizuneh Terefe, Bewuketu COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study |
title | COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study |
title_full | COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study |
title_fullStr | COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study |
title_full_unstemmed | COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study |
title_short | COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study |
title_sort | covid-19-related perceived threat following a second dose vaccination in adults with chronic illness: a mixed-method study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126288/ https://www.ncbi.nlm.nih.gov/pubmed/35615583 http://dx.doi.org/10.2147/RMHP.S365389 |
work_keys_str_mv | AT gebeyehudanielayelegne covid19relatedperceivedthreatfollowingaseconddosevaccinationinadultswithchronicillnessamixedmethodstudy AT sisayendalkachew covid19relatedperceivedthreatfollowingaseconddosevaccinationinadultswithchronicillnessamixedmethodstudy AT mollabizuneh covid19relatedperceivedthreatfollowingaseconddosevaccinationinadultswithchronicillnessamixedmethodstudy AT terefebewuketu covid19relatedperceivedthreatfollowingaseconddosevaccinationinadultswithchronicillnessamixedmethodstudy |